HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of deferoxamine on retinal lipid peroxidation in experimental uveitis.

AbstractPURPOSE:
To examine the effect of deferoxamine, an effective iron chelator, on experimental autoimmune uveitis. Because deferoxamine has been shown to reduce iron-catalyzed hydroxyl radical generation, the in vivo effect was sought in the experimental autoimmune uveitis-mediated retinal lipid peroxidation, which is presumably induced by the inflammatory cell-derived oxygen radicals including hydroxyl radicals.
METHODS:
The experimental uveitis was induced in Lewis rats by retinal S-antigen. Deferoxamine infusion by osmotic pumps was started 2 days before the onset of the disease and was continued for 7 days. The extent of retinal lipid peroxidation was measured by the production of conjugated dienes, ketodienes, and thiobarbituric acid active substances. The inflammation associated free radical activity was measured by the luminol-amplified chemiluminescence.
RESULTS:
Levels of conjugated dienes, ketodienes, and thiobarbituric acid reactive substances were significantly decreased in the deferoxamine-treated animals. With Student's t test, the P values are < 0.025 for conjugated dienes between deferoxamine- and sham-treated animals; < 0.025 for ketodienes between deferoxamine- and sham-treated animals; and < 0.01 for thiobarbituric acid reactive substances between deferoxamine- and sham-treated animals. With in vitro addition of 10 mM deferoxamine, the free radical generation of inflamed retina was suppressed by nearly 40%.
CONCLUSIONS:
The administration of deferoxamine resulted in reduction of retinal lipid peroxidation. Because photoreceptors contain a high proportion of polyunsaturated fatty acids, deferoxamine, in turn, will act to ameliorate the experimental autoimmune uveitis-mediated retinal degeneration.
AuthorsG S Wu, J Walker, N A Rao
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 34 Issue 11 Pg. 3084-9 (Oct 1993) ISSN: 0146-0404 [Print] United States
PMID8407215 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Free Radicals
  • Thiobarbituric Acid Reactive Substances
  • Deferoxamine
Topics
  • Animals
  • Choroid (metabolism, pathology)
  • Deferoxamine (administration & dosage, pharmacology)
  • Female
  • Free Radicals (metabolism)
  • Infusion Pumps, Implantable
  • Lipid Peroxidation (drug effects)
  • Rats
  • Rats, Inbred Lew
  • Retina (metabolism, pathology)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Uveitis (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: